Toll-like receptor 8: The awkward TLR;Le récepteur toll-like 8: Un TLR pas comme les autres

Medecine/Sciences

Volumn 28, Issue 1, 2012, Pages 96-102

  Alexopoulou, Lena ^a,b,c   Desnues, Benoit ^a,b,c   Demaria, Olivier ^a,b,c  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b INSERM   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOQUINOLINE DERIVATIVE; CYTOKINE; IMIQUIMOD; LIGAND; MEMBRANE PROTEIN; TLR3 PROTEIN, HUMAN; TLR3 PROTEIN, MOUSE; TLR7 PROTEIN, HUMAN; TLR7 PROTEIN, MOUSE; TLR8 PROTEIN, HUMAN; TLR8 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; VIRUS RNA;

ADAPTIVE IMMUNITY; ANIMAL; AUTOIMMUNE DISEASE; BIOLOGICAL MODEL; DRUG POTENTIATION; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; MOUSE; NEOPLASM; PHASE 1 CLINICAL TRIAL (TOPIC); PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS INFECTION;

ADAPTIVE IMMUNITY; AMINOQUINOLINES; ANIMALS; AUTOIMMUNE DISEASES; CLINICAL TRIALS, PHASE I AS TOPIC; CYTOKINES; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; LIGANDS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEMBRANE GLYCOPROTEINS; MICE; MODELS, IMMUNOLOGICAL; NEOPLASMS; RNA, VIRAL; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 8; VIRUS DISEASES;

MUS;

EID: 84856893221     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2012281023     Document Type: Review

References (40)

1. Medzhitov R. Approaching the asymptote: 20 years later. Immunity 2009;30:766-75.
2. Blasius AL, Beutler B. Intracellular Toll-like receptors. Immunity 2010;32:305-15.
3. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011;34:637-50.
4. Delneste Y, Beauvillain C, Jeannm P. Immunité naturelle: structure et fonction des Toll-like receptors. Med Sci (Paris) 2007;23:67-73. (Pubitemid 46144511)
5. Chatenoud L Immunité innée et immunité adaptative: un flirt bénéfique? Med Sci (Paris) 2002;18:1183-4.
6. Leulier F, Lemaitre B. Toll-like receptors: taking an evolutionary approach. Nat Rev Genet 2008;9:165-78. (Pubitemid 351271799)
7. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394-7. (Pubitemid 27334820)
8. Yu L, Wang L, Chen S. Endogenous Toll-like receptor ligands and their biological significance. J Cell Mol Med 2010;14:2592-603.
9. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of doublestranded RNA and activation of NF-kappaB by Toll-like receptor 3. Mature 2001;413:732-8. (Pubitemid 33009951)
10. Zhang SY, Jouanguy E, Ugolini S, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007;317:1522-7. (Pubitemid 47417427)
11. Heil F, Hemmi H, Hochrein H, et al. Species-specific recognition of singlestranded RNA via toll-like receptor 7 and 8. Science 2004;303:1526-9. (Pubitemid 38314424)
12. Kawai T, Akira S. Innate immune recognition of viral infection. Nat Immunol 2006;7:131-7. (Pubitemid 43135878)
13. Mancuso G, Gambuzza M, Midiri A, et al. Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells. Nat Immunol 2009;10:587-94.
14. Martinez J, Huang X, Yang Y. Toll-like receptor 8-mediated activation of murine plosmacytoid dendritic cells by vaccinia viral DNA. Proc Natl Acad Sci USA 2010;107:6442-7.
15. Bauer S, Bathke B, Lauterbach H, et al. A major role for TLR8 in the recognition of vaccinia viral DNA by murine pDC? Proc Natl Acad Sci USA 2010;107:E139-40.
16. Krieg AM, Love-Homan L, Yi AK, Harty JT. CpG DNA induces sustained 1L-12 expression in vivo and resistance to Listeria monocytogenes challenge. J Immunol 1998;161:2428-34. (Pubitemid 28397058)
17. Zimmermann S, Egeter O, Hausmann S, et al. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J Immunol 1998;160:3627-30. (Pubitemid 28176060)
18. Barton GM, Kagan JC, Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 2006;7:49-56. (Pubitemid 41823868)
19. Tabeta K, Hoebe K, Janssen EM, et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat Immunol 2006;7:156-64. (Pubitemid 43135881)
20. Ewald SE, Engel A, Lee J, et al. Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase. J Exp Med 2011;208:643-51.
21. Sepulveda FE, Maschatidi S, Colisson R, et al. Critical role for asparagine endopeptidase in endocytic Tall-like receptor signaling in dendritic cells. Immunity 2009;31:737-48.
22. Demaria O, Pagni PP, Traub S, et al. TLR8 deficiency leads to autoimmunity in mice. J Clin Invest 2010;120:3651-62.
23. Richez C, Blanco P, Rifkin I, et al. Role for Toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus. Joint Bone Spine 2011;78:124-30.
24. Wang J, Shao Y, Bennett TA, et al. The functional effects of physical interactions among Toll-like receptors 7, 8, and 9. J Biol Chem 2006;281:37427-34. (Pubitemid 46042046)
25. Fukui R, Saitoh S, Matsumoto F, et al. Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA-but against RNA-sensing. J Exp Med 2009;206:1339-50.
26. Crozat K, Vivier E, Dalod M. Crosstalk between components of the innate immune system: promoting anti-microbial defenses and avoiding immunopathologies. Immunol Rev 2009;227:129-49.
27. Gorden KB, Gorski KS, Gibson SJ, et al. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J Immunol 2005;174:1259-68.
28. Schon MP, Schon M. TLR7 and TLR8 as targets in cancer therapy. Oncogene 2008;27:190-9.
29. Stanley MA. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clin Exp Dermatol 2002;27:571-7. (Pubitemid 35463873)
30. Zagon IS, Donahue RN, Rogosnitzky M, McLaughlin PJ. Imiquimod upregulates the opioid growth factor receptor to inhibit cell proliferation independent of immune function. Exp Biol Med (Maywood) 2008;233:968-79.
31. Krieg AM, Vollmer J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev 2007;220:251-69. (Pubitemid 350045572)
32. Vollmer J, Tluk S, Schmitz C, et al. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J fop Med 2005;202:1575-85. (Pubitemid 41746603)
33. Sacre SM, Lo A, Gregory B, et al. Inhibitors of TLR8 reduce TNF production from human rheumatoid synovial membrane cultures. J Immunol 2008;181:8002-9.
34. Saruta M, Targan SR, Mei L, et al. High-frequency haplotypes in the X chromosome locus TLR8 are associated with both CD and UC in females. Inflamm Bowel Dis 2009;15:321-7.
35. Zhang P, Cox CJ, Alvarez KM, Cunningham MW. Cutting edge: cardiac myosin activates innate immune responses through TLRs. J Immunol 2009;183:27-31.
36. Gringhuis SI, van der Vlist M, van den Berg LM, et al. HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells. Nat Immunol 2010;11:419-26.
37. Hennessy EJ, Parker AE, O'Neill LA. Targeting Toll-like receptors: emerging therapeutics? Nat Rev Drug Discov 2010;9:293-307.
38. Levy O, Suter EE, Miller RL, Wessels MR. Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells. Blood 2006;108:1284-90. (Pubitemid 44232026)
39. Imler JL, Ferrandon D. Le printemps de l'immunité innée couronné à Stockholm. Prix Nobel de médecine 2011. Med Sci (Pans) 2011;27:1019-24.
40. Lanteri MC, Diamond MS, Norris PJ, Busch MP. Infection par le virus West Nile chez l'homme. II. Aspects physiopathologiques et réponses immunitaires. Med Sci (Paris) 2011;27:382-6.